David Gruber MD, MBA is a Managing Director and Director of Research with the Alvarez and Marsal Healthcare Industry Group (HIG) in New York, specializing in analytics, strategy, new ventures/business development, due diligence and health benefits. Before joining A&M, he spent three years as the Founder of Healthcare Convergence Associates, a consulting firm focused on the convergence of healthcare, technology and the consumer where he was also involved in three healthcare-related IT start-ups.
Until 2008, Dr. Gruber was Vice President of Corporate Development and New Ventures with the Johnson & Johnson Consumer Group of Companies. His primary focus was in dermatology / aesthetics, consumer engagement and wireless health across the company. In 1995-2004, he worked on Wall Street as a top-ten rated medical supplies and devices analyst at Lehman Brothers, Piper Jaffray and Sanford Bernstein.
Prior to entering Wall Street, Dr. Gruber was Vice President of Planning and Business Development for the $1.6 billion healthcare group at Bristol-Myers that included Zimmer, ConvaTec, Linvatec and Xomed-Treace.
Dr. Gruber is a magna cum laude graduate of a six-year BS-MD program, having received a bachelor’s degree from Sophie Davis School of Biomedical Education, CCNY in 1981 and a medical degree from the Mt. Sinai School of Medicine in 1983. He also has an MBA from Columbia University, and was a Kellogg Foundation National Fellow. Dr. Gruber is currently a Senior Fellow, Healthcare Innovation and Technology Lab (HITLAB) at Columbia Presbyterian. He is a re-elected Trustee on the Board of Education in Teaneck, NJ where he lives with his wife and three children.